Literature DB >> 21329613

FISH-based detection of 1p 19q codeletion in oligodendroglial tumors: procedures and protocols for neuropathological practice - a publication under the auspices of the Research Committee of the European Confederation of Neuropathological Societies (Euro-CNS).

A Woehrer1, P Sander, C Haberler, S Kern, H Maier, M Preusser, C Hartmann, J M Kros, J A Hainfellner.   

Abstract

The codeletion of chromosomal arms 1p 19q is a characteristic and early genetic event in oligodendroglial tumors, that is associated with a better prognosis and enhanced response to therapy. Over the last years, the increasing clinical demand to determine the 1p 19q status has led to the implementation of its testing in many neuropathology laboratories. Several different methods for 1p 19q testing are available: PCR-based loss of heterozygosity analysis, multiplex ligation-dependent probe amplification, array comparative genomic hybridization, and fluorescence in situ hybridization (FISH). Herein, we focus and critically discuss the latter method because a detailed description of procedures and protocols for FISH-based 1p 19q testing in practice is lacking. We present a practical approach to the FISH-based assessment of the 1p 19q status in oligodendroglial tumors, from commonly used locus-specific probes and technical protocols to the neuropathological interpretation of results. Thereby, we aim to facilitate the implementation of FISH-based 1p 19q testing for clinical purposes in standard neuropathology laboratories without special focus on brain tumor research.

Entities:  

Mesh:

Year:  2011        PMID: 21329613     DOI: 10.5414/npp30047

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  39 in total

Review 1.  Molecular diagnostics: techniques and recommendations for 1p/19q assessment.

Authors:  Adelheid Woehrer; Johannes A Hainfellner
Journal:  CNS Oncol       Date:  2015-11-06

2.  Microscopy with ultraviolet surface excitation for rapid slide-free histology.

Authors:  Farzad Fereidouni; Zachary T Harmany; Miao Tian; Austin Todd; John A Kintner; John D McPherson; Alexander D Borowsky; Mirna Lechpammer; John Bishop; Stavros G Demos; Richard Levenson
Journal:  Nat Biomed Eng       Date:  2017-12-04       Impact factor: 25.671

3.  Radio-chemotherapy improves survival in IDH-mutant, 1p/19q non-codeleted secondary high-grade astrocytoma patients.

Authors:  Tareq A Juratli; Tim Lautenschläger; Kathrin D Geiger; Thomas Pinzer; Mechthild Krause; Gabriele Schackert; Dietmar Krex
Journal:  J Neurooncol       Date:  2015-06-02       Impact factor: 4.130

4.  Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors.

Authors:  Irena Srebotnik-Kirbiš; Clara Limbäck-Stokin
Journal:  J Neurooncol       Date:  2016-07-12       Impact factor: 4.130

5.  Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases.

Authors:  Kiyong Na; Hyun-Soo Kim; Hyo Sup Shim; Jong Hee Chang; Seok-Gu Kang; Se Hoon Kim
Journal:  J Neurooncol       Date:  2019-02-01       Impact factor: 4.130

6.  Prognostic Value of O-(2-[18F]Fluoroethyl)-L-Tyrosine PET/CT in Newly Diagnosed WHO 2016 Grade II and III Glioma.

Authors:  Olivia Kertels; Almuth F Kessler; Milena I Mihovilovic; Antje Stolzenburg; Thomas Linsenmann; Samuel Samnick; Stephanie Brändlein; Camelia Maria Monoranu; Ralf-Ingo Ernestus; Andreas K Buck; Mario Löhr; Constantin Lapa
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.488

7.  MRI features predict survival and molecular markers in diffuse lower-grade gliomas.

Authors:  Hao Zhou; Martin Vallières; Harrison X Bai; Chang Su; Haiyun Tang; Derek Oldridge; Zishu Zhang; Bo Xiao; Weihua Liao; Yongguang Tao; Jianhua Zhou; Paul Zhang; Li Yang
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

8.  The importance of 10q status in an outcomes-based comparison between 1p/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss of heterozygosity analysis of oligodendrogliomas.

Authors:  Craig Horbinski; Marina N Nikiforova; Jonathan Hobbs; Stephanie Bortoluzzi; Kathleen Cieply; Sanja Dacic; Ronald L Hamilton
Journal:  J Neuropathol Exp Neurol       Date:  2012-01       Impact factor: 3.685

9.  Something old and something new about molecular diagnostics in gliomas.

Authors:  Craig Horbinski
Journal:  Surg Pathol Clin       Date:  2012-12-01

10.  How molecular testing can help (and hurt) in the workup of gliomas.

Authors:  Kenneth Clark; Zoya Voronovich; Craig Horbinski
Journal:  Am J Clin Pathol       Date:  2013-03       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.